Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.

about

Serum interleukin-6 levels as an indicator of aseptic meningitis among children with enterovirus 71-induced hand, foot and mouth disease.

P2860

Q48135665-AB9B1CA3-6159-4596-B624-4156013C2F78

P2860

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.

Item

http://www.wikidata.org/entity/Q54079810

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Correlates of protection for i ...... nological surrogate endpoints.

@en

Correlates of protection for i ...... nological surrogate endpoints.

@nl

type

Item

label

Correlates of protection for i ...... nological surrogate endpoints.

@en

Correlates of protection for i ...... nological surrogate endpoints.

@nl

prefLabel

Correlates of protection for i ...... nological surrogate endpoints.

@en

Correlates of protection for i ...... nological surrogate endpoints.

@nl

P1476

Correlates of protection for i ...... nological surrogate endpoints.

@en

P2093

Feng-Cai Zhu

http://www.w3.org/2001/XMLSchema#string

Jing-Xin Li

http://www.w3.org/2001/XMLSchema#string

Pei Liu

http://www.w3.org/2001/XMLSchema#string

Pengfei Jin

http://www.w3.org/2001/XMLSchema#string

Wenbo Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines.

Enterovirus 71 outbreaks, Taiwan: occurrence and recognition.

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial.

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Some extensions in continuous models for immunological correlates of protection.

Validation and evaluation of serological correlates of protection for inactivated enterovirus 71 vaccine in children aged 6-35 months.

Development of enterovirus 71 vaccines.

Update on the development of enterovirus 71 vaccines.

A threshold method for immunological correlates of protection.

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.

P304

945-949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14760584.2017.1335603

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28548626

http://www.w3.org/2001/XMLSchema#string

P921

immunology

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.

about

P2860

P2860

Correlates of protection for inactivated enterovirus 71 vaccine: the analysis of immunological surrogate endpoints.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921